METHODS OF TREATING ISCHEMIA-REPERFUSION INJURY WITH siRNAS

The disclosure relates to compounds, in particular siRNAs that inhibit the expression of specific human genes, for treating ocular diseases or disorders. The invention also relates to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The present disclos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Kalinski Hagar, Feinstein Elena
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosure relates to compounds, in particular siRNAs that inhibit the expression of specific human genes, for treating ocular diseases or disorders. The invention also relates to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The present disclosure also provides methods of treating and/or preventing the incidence or severity of various ocular diseases or disorders associated with the genes associated with such diseases or disorders by administering to a subject in need of treatment for such disease or disorder the compounds or pharmaceutical compositions in a therapeutically effective dose.